Pharmaceutical Filtration Market Size, Share, Trends, Growth 2030

Pharmaceutical Filtration Industry Prospective:

The global pharmaceutical filtration market size was worth around USD 10.5 Billion in 2021 and is predicted to grow to around USD 41.5 Billion by 2030 with a compound annual growth rate (CAGR) of roughly 16.5% between 2022 and 2030.

The report analyzes the global pharmaceutical filtration market’s drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the pharmaceutical filtration market.

Request Free Sample

Pharmaceutical Filtration Market: Overview

In the pharmaceutical and biopharmaceutical sectors, filtration is a technique for separating particles from fluids by inserting a medium through which only the fluid may flow. Filtration promotes the production of both small and big molecules by avoiding cross-contamination. This method frequently goes together with other processes.

The materials are separated by a single perforated layer. This strategy is used in the processes of filtering water, bulk materials, and solvents. There are three different types of operations available on the market: manufacturing-scale operations, pilot-scale operations, and R&D-scale operations. By preventing contamination, the filters aid in maintaining the sterility of the treated fluid.

Key Insights

• As per the analysis shared by our research analyst, the global pharmaceutical filtration market is estimated to grow annually at a CAGR of around 16.5% over the forecast period (2022-2030).
• In terms of revenue, the global pharmaceutical filtration market size was valued at around USD 10.5 billion in 2021 and is projected to reach USD 41.5 billion, by 2030.
• Global demand for generic medications has increased as a result of significant growth in the incidence of chronic diseases. This is one of the primary factors behind the market’s growth, coupled with strict rules for drug quality assessment.
• Based on the product, the membrane filter segment is expected to hold the largest market share over the forecast period.
• Based on the technique, microfiltration holds the largest revenue share over the forecast period.
• Based on the scale of operations, the manufacturing scale of operations retained the highest market share in 2021.
• Based on region, North America is expected to dominate the market during the forecast period.

Request Free Sample

To know more about this report, Request a sample copy

Pharmaceutical Filtration Market: Growth Drivers

The rising number of chronic diseases across the globe drives the market growth

One of the main drivers of the pharmaceutical industry’s expansion is the rise of chronic conditions on a worldwide scale. Advanced therapeutic medications are in high demand for the treatment of chronic disorders including cancer, diabetes, asthma, COPD, and arthritis. For instance, globally, there were 17.0 million new instances of cancer and 9.5 million cancer-related deaths in 2018, according to estimates from the International Agency for Research on Cancer (IARC).

Simply because of population expansion and age, it is anticipated that by 2040 there would be 16.3 million cancer deaths and 27.5 million new cancer cases worldwide. Due to the rising frequency of risk factors including smoking, poor food, physical inactivity, and fewer pregnancies in economically developing nations, the burden will likely grow in the future. Thus, the rising prevalence of chronic diseases across the globe is expected to drive the growth of the global pharmaceutical filtration market during the forecast period.

Pharmaceutical Filtration Market: Restraints

Increased cost reduced speed and yield limits the market growth

For the intermediate and final filtering of liquid medicinal formulations, sterilizing grade membrane filters are frequently employed. But during the past few decades, these filters have rapidly developed and improved, which has improved their thermal and mechanical resistance. The price of these filters has grown due to their greater efficiency, which has also influenced their cost. Thus, acting as a major restraint on the growth of the pharmaceutical filtration industry.

Pharmaceutical Filtration Market: Opportunities

Technological advancements provide a lucrative opportunity

The pharmaceutical filtering industry is expanding as a result of technological advancements. According to a report from July 2019, one of the largest worldwide vaccine manufacturers decided to use a system based on membrane bioreactor (MBR) technology when it came time to build a water treatment facility for its innovative pharmaceutical production facility.

The facility, which is located in Pune, India, was chosen because it could be built with a small footprint and still produce high-quality water that would pass through ultrafiltration (UF). MBR systems are robust and can handle cyclical changes. In addition to consistently producing superior effluent quality in terms of total suspended solids (TSS) and organic elimination, membranes used as a physical barrier for solid-liquid segregation also require fewer chemicals for disinfection. Flat-sheet, submerged EnviQTM UF membranes have a consistent pore size.

These membranes don't require any forceful backwashing, are easier to operate, and are less prone to clogging. Thus, these types of technological advancements will provide a lucrative opportunity over the forecast period.

Pharmaceutical Filtration Market: Challenges

Limitations of barrier-based filtration and stringent regulation act as a major challenge

The main drawbacks of barrier-based filtration are the high costs of replacement and disposal. This type of filter has to be replaced when it becomes clogged with waste particles. This can become costly over time, both in terms of the cost of replacement filters and the amount of downtime required to remove & replace worn-out filters. Additionally, it is imperative to strictly abide by the binding regulations, such as PDA TR26, that have strict requirements for sterilization validation, such as "Product sterilization may not be achieved with integral "sterilizing grade" filter cartridges" and "Sterilization of drug product should be validated." These problems are impeding the global pharmaceutical filtration market's expansion.

Pharmaceutical Filtration Market: Segmentation

The global pharmaceutical filtration market is segmented based on product, system, type, technique, application, scale of operation, and region.

Based on the product, the global market is bifurcated into membrane filters, prefilters & depth media, single-use systems, cartridges & capsules, filter holders, filtration accessories, and others. The membrane filters segment is expected to hold the largest market share over the forecast period due to the fast expansion of the pharmaceutical and biologics industries. To increase their market share as much as possible, these companies are engaging in partnerships and collaborations.

For instance, Novartis and Xencor Inc. collaborated strategically in June 2016 to provide Novartis with the right to create T-cell-engaging, bispecific antibodies for the treatment of B-cell and acute myeloid leukemia. The production and development procedures, including sterile filtration and end-stage operations, frequently employ membrane filters. Thus, the need for cutting-edge medications and vaccinations is anticipated to expand significantly in the near future due to the rise in the occurrence of viral and chronic diseases including anthrax, measles, influenza, TB, and chickenpox. The CDC estimates that between 5 and 20 percent of Americans get the flu each year.

Based on the system, the market is segmented into single-use and reusable.

Based on the type, the market is segmented into sterile and non-sterile.

Based on the technique, the market is bifurcated into microfiltration, ultrafiltration, crossflow filtration, nanofiltration, and others. Microfiltration holds the largest revenue share over the forecast period. Macromolecules, colloids, and suspended particles can all be concentrated, purified, or separated from the solution using the pressure-driven separation technique known as microfiltration (MF). It is often employed to cold sterilize medications. It has been demonstrated that adding heat reduces the efficacy of medications.

To sterilize liquids without using heat, MF membranes are used in a process known as "cold sterilization" to eliminate bacteria and other undesirable substances. As pharmaceutical research and drug development have risen in recent decades, so has the utilization of microfiltration technology. As a result, microfiltration has taken center stage in pharmaceutical research and development, and demand for the technology is only going to grow in the coming years.

Based on the application, global pharmaceutical filtration is divided into final product processing, raw material filtration, cell separation, water purification, and air purification.

Based on the scale of operation, the global market is segmented into manufacturing scale, pilot-scale, and research & development scale. The manufacturing scale of operations retained the highest market share in 2021 as a result of the rise in the manufacture of biopharmaceuticals, generic medications, and vaccines that are used to treat a variety of ailments. Due to the rising need for innovative biologics and therapeutic proteins for the treatment of chronic diseases, the manufacturing scale of operations is anticipated to flourish over the forecast period as well.

The segment's expansion is anticipated to be aided by the increased prevalence of chronic disorders including cancer, arthritis, and diabetes. The CDC reports that there are around 54 million arthritis patients in the United States. As a result, there is a significant need for downstream processing products that are effective and productive, which is expected to promote growth.

Recent Developments:

• In November 2021, vacuum filtration machines were developed by the life science company Sartorius to provide superior physical stability and quicker and higher capacity filtering for a variety of sample types. For the study and filtration of small volumes ranging from 50 ml to one liter, Sartolab RF|BT vacuum filtration devices are created. With its wide filter area, low protein affinity membrane to reduce protein loss, and improved membrane support for a small hold-up volume, the units provide the maximum flow rates.
• In January 2021, the 3M Petrifilm Plate Reader Advanced was unveiled by 3M Food Safety to speed up production and free up lab testing time. According to the company, food safety specialists may quickly and accurately visualize, count, and record microbial colonies on 3M Petrifilm Plates indication tests using automated technology.

Pharmaceutical Filtration Market Report Scope:

Pharmaceutical Filtration Market: Regional Analysis

North America is expected to dominate the market during the forecast period

North America is expected to the global pharmaceutical filtration dominate the market during the forecast period. The healthcare systems in the US and Canada are developed and well-organized. These nations support pharmaceutical research and development as well, which contributes to their high healthcare costs.

These regulations encourage numerous businesses all around the world to operate in this region. The US is home to many of the major pharmaceutical companies' corporate offices and research facilities. Membrane chromatography is necessary for pharmaceutical research, therefore North America has a significant need for these technologies and techniques.

This substantial percentage can be attributable to the increased R&D spending by North American biopharmaceutical businesses as well as the expanding demand for biopharmaceuticals.

On the other hand, the Asia Pacific is expected to grow at the highest CAGR during the forecast period due to the untapped pharmaceutical filtration industry potential. This region has seen tremendous growth as a result of the rise of pharmaceutical and biopharmaceutical firms. Heavy expenditures by CMOs and CROs in the manufacturing of medicines and biologics, as well as less severe regulatory requirements, all work in favor of these firms, propelling market expansion.

The development of healthcare infrastructure and the availability of huge genomic pools are important factors driving market expansion.

Pharmaceutical Filtration Market: Competitive Analysis

The global pharmaceutical filtration market is dominated by players like:

• Danaher
• GE Healthcare
• GEA Group
• Graver Technologies
• Merck Millipore
• Parker Hannifin Corporation
• Repligen Corporation
• Sartorius Stedim Biotech
• Thermo Fisher Scientific
• 3M
• Eaton
• Antylia Scientific (Cole-Parmer)

The global pharmaceutical filtration market is segmented as follows:

By Product

• Membrane Filters
• Prefilters & Depth Media
• Single-use Systems
• Cartridges & Capsules
• Filter Holders
• Filtration Accessories
• Others

By System

• Single Use
• Reusable

By Type

• Sterile
• Non Sterile

By Technique

• Microfiltration
• Ultrafiltration
• Crossflow Filtration
• Nanofiltration
• Others

By Application

• Final Product Processing
• Raw Material Filtration
• Cell Separation
• Water Purification
• Air Purification

By Scale of Operation

• Manufacturing Scale
• Pilot-scale
• Research & Development Scale

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France 
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa